Difference between revisions of "LncRNAWiki:Kidney-cancer"
| Line 72: | Line 72: | ||
|Pvt1 oncogene (non-protein coding) | |Pvt1 oncogene (non-protein coding) | ||
|"breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer" | |"breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer" | ||
| + | |- | ||
| + | |''LNCSRLR'' | ||
| + | |[[LNCSRLR]] | ||
| + | |lncRNA-SRLR | ||
| + | |lncRNA sorafenib resistance in renal cell carcinoma associated | ||
| + | |renal cell carcinoma | ||
| + | |- | ||
| + | |''TRIM52-AS1'' | ||
| + | |[[TRIM52-AS1]] | ||
| + | |N/A | ||
| + | |TRIM52 antisense RNA 1 (head to head) | ||
| + | |renal cell carcinoma | ||
| + | |||
|} | |} | ||
Latest revision as of 09:00, 28 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| CYP51A1-AS1 | CYP51A1-AS1 | ENST00000453068, LRRD1-AS1 | CYP51A1 antisense RNA 1 | renal cell carcinoma |
| LBX2-AS1 | LBX2-AS1 | N/A | LBX2 antisense RNA 1 | renal cell carcinoma, kidney-cancer |
| DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
| MALAT1 | ENST00000534336.1 | HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | kidney-cancer |
| GAS5 | NONHSAT007663 | SNHG2, ENSG00000234741 | _ | autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus |
| H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | "H19, imprinted maternally expressed transcript (non-protein coding)" | "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" |
| MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) | kidney-cancer |
| KCNQ1OT1 | NONHSAT017524 | "KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12""" | KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) | kidney-cancer |
| HIF1A-AS1 | HIF1A-AS1 | 5'aHIF-1A | HIF1A antisense RNA 1 | kidney cancer |
| HIF1A-AS2 | HIF1A-AS2 | 3'aHIF-1A, aHIF | HIF1A antisense RNA 2 | kidney cancer |
| PVT1 | ENST00000513868.2 | NCRNA00079, LINC00079, onco-lncRNA-100 | Pvt1 oncogene (non-protein coding) | "breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer" |
| LNCSRLR | LNCSRLR | lncRNA-SRLR | lncRNA sorafenib resistance in renal cell carcinoma associated | renal cell carcinoma |
| TRIM52-AS1 | TRIM52-AS1 | N/A | TRIM52 antisense RNA 1 (head to head) | renal cell carcinoma |
